Nutex Health Inc.
NUTX
$187.60
$1.760.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 219.31% | 30.81% | 35.88% | 393.11% | 248.71% |
| Total Depreciation and Amortization | 1.97% | 5.29% | 8.21% | 12.25% | 13.48% |
| Total Amortization of Deferred Charges | -54.29% | -26.67% | -13.44% | 30.13% | 15.71% |
| Total Other Non-Cash Items | -66.25% | 77.28% | 340.77% | 544.75% | 536.73% |
| Change in Net Operating Assets | 102.24% | 66.72% | 15.82% | -16,815.81% | -17,922.26% |
| Cash from Operations | 228.72% | 283.69% | 971.68% | 733.80% | 415.44% |
| Capital Expenditure | -103.35% | -387.77% | -196.79% | -223.64% | -14.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 100.00% | 149.23% |
| Other Investing Activities | -- | 154.27% | 154.27% | -- | -- |
| Cash from Investing | -162.60% | -29.21% | 6.49% | -149.64% | 27.03% |
| Total Debt Issued | -98.03% | -90.16% | -45.64% | -47.02% | -12.12% |
| Total Debt Repaid | -33.54% | -74.12% | -46.82% | -15.71% | 9.18% |
| Issuance of Common Stock | -64.61% | -64.96% | -94.86% | -60.96% | -40.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -260.23% | -517.59% | -1,053.71% | -890.59% | -431.91% |
| Cash from Financing | -525.01% | -1,133.33% | -9,077.91% | -33,951.44% | -595.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.83% | 129.54% | 677.63% | 493.29% | 594.40% |